SMLR Stock Price, Semler Scientific, Inc. Quote, Chart

Market Summary

USD23.21-0.46

Delayed

-1.94%

SMLR Stock Price

View Fullscreen

SMLR RSI Chart

SMLR Valuation

Market Cap

164.0M

Price/Earnings (Trailing)

7.56

Price/Sales (Trailing)

2.49

EV/EBITDA

3.9

Price/Free Cashflow

6.35

SMLR Price/Sales (Trailing)

SMLR Profitability

Operating Margin

89.43%

EBT Margin

38.35%

Return on Equity

27.84%

Return on Assets

25.86%

Free Cashflow Yield

15.76%

SMLR Fundamentals

SMLR Revenue

Revenue (TTM)

65.9M

Rev. Growth (Yr)

-12.65%

Rev. Growth (Qtr)

5.62%

SMLR Earnings

Earnings (TTM)

21.7M

Earnings Growth (Yr)

22.22%

Earnings Growth (Qtr)

43.88%

Breaking Down SMLR Revenue

Last 7 days

1.3%

Last 30 days

-9.5%

Last 90 days

-52.3%

Trailing 12 Months

-21.5%

How does SMLR drawdown profile look like?

SMLR Financial Health

Current Ratio

12.18

SMLR Investor Care

Shares Dilution (1Y)

3.13%

Diluted EPS (TTM)

2.78

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	65.9M	0	0	0
2023	60.9M	64.7M	66.9M	68.2M
2022	53.9M	54.4M	54.4M	56.7M
2021	42.4M	50.3M	53.6M	53.0M
2020	35.4M	33.9M	35.7M	38.6M
2019	23.8M	26.3M	29.6M	32.8M
2018	14.9M	17.8M	19.7M	21.5M
2017	8.0M	8.9M	10.6M	12.5M
2016	7.3M	7.6M	8.1M	7.4M
2015	4.0M	4.5M	5.1M	7.0M
2014	2.7M	3.1M	3.4M	3.6M
2013	0	0	0	2.3M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Semler Scientific, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Sep 13, 2023	semler eric	bought	755,260	28.11	26,868	-
Sep 12, 2023	semler eric	bought	717,513	27.7	25,903	-
Sep 11, 2023	semler eric	bought	674,500	26.98	25,000	-
May 31, 2023	messina daniel s	acquired	-	-	909	-
Feb 01, 2023	messina daniel s	acquired	-	-	3,045	-
Feb 01, 2023	pan wayne t	acquired	-	-	2,436	-
Feb 01, 2023	leibowitz arthur n	acquired	-	-	2,436	-
Feb 01, 2023	moon cindy	acquired	-	-	2,436	-
Feb 01, 2023	moon cindy	sold (taxes)	-43,964	41.05	-1,071	-
Nov 04, 2022	william h.c. chang & diana shon chang ttee chang family trust u/a dtd 10/23/2006	gifted	-	-	-105,582	-

Which funds bought or sold SMLR recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-38.97	-20,033	13,495	-%
May 16, 2024	JANE STREET GROUP, LLC	sold off	-100	-313,130	-	-%
May 15, 2024	Palouse Capital Management, Inc.	new	-	126,187	126,187	0.08%
May 15, 2024	BOKF, NA	new	-	226,794	226,794	-%
May 15, 2024	STATE STREET CORP	added	1.11	-1,332,970	2,667,920	-%
May 15, 2024	DEUTSCHE BANK AG\	reduced	-11.23	-49,386	69,754	-%
May 15, 2024	JANUS HENDERSON GROUP PLC	reduced	-4.04	-345,917	596,264	-%
May 15, 2024	CITADEL ADVISORS LLC	new	-	932,237	932,237	-%
May 15, 2024	GOLDMAN SACHS GROUP INC	sold off	-100	-552,429	-	-%
May 15, 2024	MARSHALL WACE, LLP	reduced	-69.98	-1,195,750	295,226	-%

Are Funds Buying or Selling SMLR?

Are funds buying SMLR calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own SMLR

No. of Funds

Unveiling Semler Scientific, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 12, 2024	topline capital management, llc	0%	0	SC 13G/A
Jan 26, 2024	altravue capital, llc	1.%	0	SC 13G/A
Sep 14, 2023	semler eric	9.4%	645,992	SC 13D/A
May 17, 2023	murphy-chutorian douglas	10.32%	784,571	SC 13D/A
Apr 20, 2023	semler eric	8.3%	568,221	SC 13D/A
Apr 20, 2023	william h.c. chang & diana shon chang ttee chang family trust u/a dtd 10/23/2006	9.38%	641,991	SC 13D/A
Feb 15, 2023	topline capital management, llc	5.8%	399,860	SC 13G
Feb 14, 2023	park west asset management llc	0%	0	SC 13G/A
Jan 19, 2023	altravue capital, llc	6.39%	437,277	SC 13G/A
Jan 05, 2023	william h.c. chang & diana shon chang ttee chang family trust u/a dtd 10/23/2006	9.38%	641,991	SC 13D/A

Recent SEC filings of Semler Scientific, Inc.

View All Filings

Date Filed	Form Type	Document
May 14, 2024	4	Insider Trading
May 14, 2024	4	Insider Trading
May 14, 2024	4	Insider Trading
May 14, 2024	4	Insider Trading
May 14, 2024	4	Insider Trading
May 08, 2024	10-Q	Quarterly Report
May 07, 2024	8-K	Current Report
Mar 07, 2024	10-K	Annual Report
Mar 05, 2024	8-K	Current Report
Feb 12, 2024	SC 13G/A	Major Ownership Report

Peers (Alternatives to Semler Scientific, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	181.0B	40.3B	-1.75%	-4.07%	32.18	4.49	-2.84%	-3.08%
BDX	68.3B	19.7B	1.78%	-6.05%	51.24	3.46	4.82%	-17.56%
ALGN	20.4B	3.9B	-9.57%	-7.50%	44.2	5.22	5.72%	46.72%
BAX	18.0B	14.9B	-10.73%	-18.01%	6.79	1.21	2.98%	207.68%
MID-CAP
ATR	9.8B	3.5B	6.68%	24.08%	31.27	2.76	6.16%	35.06%
HSIC	9.6B	12.5B	6.31%	-2.51%	24.63	0.77	-0.61%	-18.83%
BIO	8.4B	2.6B	1.13%	-22.65%	-26.02	3.22	-6.25%	-68.62%
XRAY	5.9B	3.9B	-6.79%	-30.12%	-62.84	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	0.52%	31.17%	-216.3	8.9	30.82%	65.57%
PDCO	2.3B	6.6B	0.19%	-5.50%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	5.94%	-10.00%	-1.91	0.41	7.94%	-1661.78%
ANIK	376.6M	169.3M	-1.13%	-2.23%	-4.9	2.23	7.49%	-244.90%
ANGO	241.9M	324.0M	-4.58%	-37.15%	-1.26	0.75	-3.19%	-337.41%
APYX	56.1M	50.5M	22.73%	-73.49%	-2.46	1.11	14.25%	-10.06%
AEMD	1.0M	3.7M	-71.13%	32.26%	-0.09	0.28	5.77%	8.23%

Semler Scientific, Inc. News

Latest updates

Semler Scientific, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	5.6%	16.00	15.00	16.00	19.00	18.00	14.00	14.00	15.00	14.00	12.00	14.00	14.00	13.00	12.00	11.00	6.00	9.00	9.00	9.00	8.00	7.00
Cost Of Revenue	-63.2%	1.00	3.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	2.00	1.00	1.00	2.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Costs and Expenses	-28.8%	9.00	13.00	10.00	11.00	12.00	10.00	10.00	10.00	10.00	10.00	9.00	8.00	7.00	6.00	5.00	5.00	6.00	6.00	6.00	5.00	5.00
Operating Expenses	-5.7%	1.00	1.00	1.00	2.00	2.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
S&GA Expenses	-19.2%	4.00	5.00	3.00	5.00	5.00	5.00	4.00	4.00	5.00	4.00	4.00	4.00	3.00	3.00	2.00	2.00	3.00	2.00	2.00	2.00	2.00
EBITDA Margin	8.6%	0.39*	0.36*	0.42*	0.39*	0.36*	0.33*	0.30*	0.31*	0.33*	0.38*	0.46*	0.50*	0.46*	-	-	-	-	-	-	-	-
Interest Expenses	-	-	-	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	-
Income Taxes	222.5%	2.00	-1.41	1.00	2.00	2.00	1.00	1.00	1.00	1.00	0.00	1.00	-0.21	1.00	1.00	1.00	-0.08	1.00	0.00	-4.67	0.00	-
Earnings Before Taxes	177.1%	8.00	3.00	7.00	8.00	7.00	4.00	5.00	5.00	4.00	2.00	5.00	6.00	6.00	6.00	6.00	1.00	3.00	3.00	3.00	3.00	2.00
EBT Margin	8.5%	0.38*	0.35*	0.38*	0.35*	0.33*	0.31*	0.28*	0.30*	0.32*	0.37*	0.45*	0.49*	0.45*	-	-	-	-	-	-	-	-
Net Income	43.9%	6.00	4.00	6.00	6.00	5.00	3.00	4.00	4.00	3.00	2.00	4.00	7.00	5.00	5.00	5.00	1.00	3.00	3.00	8.00	3.00	2.00
Net Income Margin	9.0%	0.33*	0.30*	0.29*	0.27*	0.26*	0.25*	0.23*	0.24*	0.29*	0.32*	0.39*	0.43*	0.38*	-	-	-	-	-	-	-	-
Free Cashflow	27.5%	6.00	4.00	5.00	11.00	1.00	2.00	8.00	6.00	1.00	2.00	8.00	2.00	4.00	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	7.4%	84.00	78.00	79.00	75.00	70.00	63.00	61.00	58.00	55.00	51.00	51.00	46.00	41.00	35.00	28.00	21.00	20.00	18.00	19.00	10.00	9.00
Current Assets	9.0%	72.00	66.00	64.00	61.00	56.00	49.00	52.00	49.00	50.00	46.00	46.00	41.00	33.00	27.00	22.00	15.00	13.00	11.00	12.00	8.00	7.00
Cash Equivalents	9.9%	63.00	57.00	37.00	39.00	5.00	23.00	46.00	40.00	38.00	37.00	36.00	29.00	26.00	22.00	17.00	14.00	11.00	8.00	9.00	4.00	5.00
Inventory	-8.3%	0.00	0.00	0.00	0.00	1.00	0.00	1.00	1.00	1.00	1.00	2.00	2.00	1.00	0.00	-	-	-	-	-	-	-
Net PPE	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	-4.8%	6.00	6.00	9.00	10.00	9.00	7.00	8.00	7.00	6.00	5.00	7.00	6.00	5.00	5.00	6.00	4.00	4.00	5.00	5.00	4.00	3.00
Shareholder's Equity	8.5%	78.00	72.00	71.00	65.00	61.00	56.00	52.00	51.00	49.00	46.00	44.00	40.00	35.00	30.00	22.00	17.00	16.00	13.00	14.00	6.00	6.00
Retained Earnings	10.2%	66.00	60.00	56.00	50.00	44.00	39.00	36.00	32.00	28.00	25.00	23.00	19.00	13.00	8.00	2.00	-2.59	-3.66	-6.33	-9.17	-16.95	-19.56
Additional Paid-In Capital	0.3%	12.00	12.00	15.00	15.00	17.00	16.00	16.00	18.00	21.00	21.00	21.00	21.00	23.00	22.00	20.00	20.00	19.00	19.00	23.00	23.00	26.00
Shares Outstanding	0.5%	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	115	-	-	-	155	-	-	-	472	-	-	-	193	-	-	-	171	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	26.6%	5,624	4,442	4,831	11,196	861	1,710	8,021	6,230	1,502	1,657	7,637	2,156	4,606	5,546	3,510	2,355	3,703	3,635	4,710	2,680	1,703
Share Based Compensation	-27.0%	27.00	37.00	47.00	158	702	33.00	32.00	48.00	628	67.00	47.00	46.00	589	63.00	62.00	61.00	67.00	83.00	86.00	98.00	98.00
Cashflow From Investing	-100.4%	-81.00	18,629	-6,778	24,969	-18,424	-24,307	-491	-1,781	-256	-223	-227	-159	-216	-316	-467	10.00	-233	-490	-366	-386	-456
Cashflow From Financing	100.3%	11.00	-3,236	-51.00	-1,975	-146	75.00	-2,025	-2,844	-143	-41.00	9.00	36.00	9.00	56.00	104	67.00	3.00	-3,946	16.00	-2,656	13.00
Buy Backs	-	-	-	-	-	-	-	2,046	2,846	99.00	-	-	-	-	-	-	-	-	-	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

SMLR Income Statement

2024-03-31

Condensed Statements of Income - USD ($) $ in Thousands	3 Months Ended
Condensed Statements of Income - USD ($) $ in Thousands	Mar. 31, 2024	Mar. 31, 2023
Condensed Statements of Income
Revenues	$ 15,903	$ 18,206
Operating expenses:
Cost of revenues	1,247	1,269
Engineering and product development	1,138	1,630
Sales and marketing	3,675	5,192
General and administrative	2,867	3,859
Total operating expenses	8,927	11,950
Income from operations	6,976	6,256
Interest and dividend income	819	484
Change in fair value of notes held for investment		(107)
Other income	2
Other income, net	821	377
Pre-tax income	7,797	6,633
Income tax provision	1,724	1,664
Net income	$ 6,073	$ 4,969
Net income per share, basic	$ 0.88	$ 0.74
Weighted average number of shares used in computing basic net income per share	6,892,742	6,701,199
Net income per share, diluted	$ 0.78	$ 0.63
Weighted average number of shares used in computing diluted net income per share	7,782,393	7,896,043

SMLR Balance Sheet

2024-03-31

Condensed Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 62,754	$ 57,200
Restricted cash	132	132
Trade accounts receivable, net of allowance for credit losses of $239 and $287, respectively	6,132	6,125
Inventory, net	408	445
Prepaid expenses and other current assets	2,479	2,042
Total current assets	71,905	65,944
Assets for lease, net	2,071	2,285
Property and equipment, net	649	720
Long-term investments	512	512
Notes held for investment (includes measured at fair value of $4,372)	5,372	5,372
Other non-current assets	249	270
Deferred tax assets	3,098	2,962
Total assets	83,856	78,065
Current liabilities:
Accounts payable	410	402
Accrued expenses	4,305	4,502
Deferred revenue	996	1,120
Other short-term liabilities	192	176
Total current liabilities	5,903	6,200
Long-term liabilities:
Other long-term liabilities	47	70
Total long-term liabilities	47	70
Commitments and contingencies (Note 14)
Stockholders' equity:
Common stock, $0.001 par value; 50,000,000 shares authorized; 7,134,193 and 7,099,441 shares issued, and 6,919,771 and 6,885,019 shares outstanding (treasury shares of 214,422 and 214,422), respectively	7	7
Additional paid-in capital	12,023	11,985
Retained earnings	65,876	59,803
Total stockholders' equity	77,906	71,795
Total liabilities and stockholders' equity	$ 83,856	$ 78,065

About Semler Scientific, Inc.

Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups, long-term care, or remote patient monitoring organizations. It offers its products through salespersons and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

CEO	Dr. Douglas Murphy-Chutorian M.D.
WEBSITE	semlerscientific.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	127

Semler Scientific, Inc. Frequently Asked Questions

What is the ticker symbol for Semler Scientific, Inc.? What does SMLR stand for in stocks?

SMLR is the stock ticker symbol of Semler Scientific, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Semler Scientific, Inc. (SMLR)?

As of Fri May 17 2024, market cap of Semler Scientific, Inc. is 164 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SMLR stock?

You can check SMLR's fair value in chart for subscribers.

What is the fair value of SMLR stock?

You can check SMLR's fair value in chart for subscribers. The fair value of Semler Scientific, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Semler Scientific, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SMLR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Semler Scientific, Inc. a good stock to buy?

The fair value guage provides a quick view whether SMLR is over valued or under valued. Whether Semler Scientific, Inc. is cheap or expensive depends on the assumptions which impact Semler Scientific, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SMLR.

What is Semler Scientific, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, SMLR's PE ratio (Price to Earnings) is 7.56 and Price to Sales (PS) ratio is 2.49. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SMLR PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Semler Scientific, Inc.'s stock?

In the past 10 years, Semler Scientific, Inc. has provided 0.192 (multiply by 100 for percentage) rate of return.